Literature DB >> 2435800

Autocrine growth function of human interleukin 1 molecules on ROHA-9, an EBV-transformed human B cell line.

G Scala, G Morrone, M Tamburrini, F Alfinito, C I Pastore, G D'Alessio, S Venuta.   

Abstract

In this study we report that the ROHA-9 cell line, an IL 1-secreting EBV-transformed human B cell line, exhibits an autocrine pathway of growth. In fact, ROHA-9 cells spontaneously secreted an autoregulatory growth factor that co-purified with the constitutively secreted IL 1-like molecules. Accordingly, monocyte-derived human IL 1, free of other known biological activities, also stimulated the growth of ROHA-9 cells in a dose-dependent way. Human recombinant interleukin 2, recombinant IFN-alpha or IFN-gamma and purified IFN-beta were ineffective when used at concentrations up to 1 X 10(3) U/ml. Furthermore, mouse recombinant IL 1, HPLC-purified multi-colony stimulating factor and partially purified preparations of BCGF were ineffective when assayed for growth-promoting activity on ROHA-9 cells. Moreover, a rabbit polyclonal antibody and a mouse monoclonal antibody to human IL 1 molecules blocked the growth of ROHA-9 cells induced by the autologous growth factor and by human IL 1. Lastly, purified human IL 1 increased the clonal efficiency of ROHA-9 cells seeded at a low cell concentration, allowing the isolation of the ROHA-9MC3 subclone, which showed similar growth response specificity and was particularly sensitive to the mitogenic activity of human IL 1.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2435800

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  8 in total

1.  Factor(s) required by EBV transformed lymphocytes to grow under limiting dilution conditions.

Authors:  C Negri; R Chiesa; G C Ricotti
Journal:  Cytotechnology       Date:  1991-11       Impact factor: 2.058

2.  Activity of soluble factors produced by Epstein-Barr virus-transformed human B lymphocytes on different cell lines.

Authors:  C Garzelli; A Bazzichi
Journal:  Experientia       Date:  1991-07-15

3.  Mechanism of autocrine stimulation in hematopoietic cells producing interleukin-3 after retrovirus-mediated gene transfer.

Authors:  T M Browder; J S Abrams; P M Wong; A W Nienhuis
Journal:  Mol Cell Biol       Date:  1989-01       Impact factor: 4.272

4.  Overexpression of the human BCL-2 gene product results in growth enhancement of Epstein-Barr virus-immortalized B cells.

Authors:  Y Tsujimoto
Journal:  Proc Natl Acad Sci U S A       Date:  1989-03       Impact factor: 11.205

5.  Epstein-Barr virus nuclear antigen 2 transactivates the long terminal repeat of human immunodeficiency virus type 1.

Authors:  G Scala; I Quinto; M R Ruocco; M Mallardo; C Ambrosino; B Squitieri; P Tassone; S Venuta
Journal:  J Virol       Date:  1993-05       Impact factor: 5.103

6.  Expression of an exogenous interleukin 6 gene in human Epstein Barr virus B cells confers growth advantage and in vivo tumorigenicity.

Authors:  G Scala; I Quinto; M R Ruocco; A Arcucci; M Mallardo; P Caretto; G Forni; S Venuta
Journal:  J Exp Med       Date:  1990-07-01       Impact factor: 14.307

7.  Growth regulation and co-stimulation of human colorectal cancer cell lines by insulin-like growth factor I, II and transforming growth factor alpha.

Authors:  H Lahm; L Suardet; P L Laurent; J R Fischer; A Ceyhan; J C Givel; N Odartchenko
Journal:  Br J Cancer       Date:  1992-03       Impact factor: 7.640

8.  Stimulatory effect of interleukin-1 alpha on proliferation through a Ca2+/calmodulin-dependent pathway of a human thyroid carcinoma cell line, NIM 1.

Authors:  N Inokuchi; K Zeki; I Morimoto; Y Nakano; T Fujihira; U Yamashita; N Yanagihara; F Izumi; S Eto
Journal:  Jpn J Cancer Res       Date:  1995-07
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.